基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research
Dr. Mody’s primary research interest includes use of precision oncology approach for designing innovative clinical trials for refractory childhood cancers. Dr. Mody is leading a clinical trial investigating the role of next generation sequencing (NGS) in precision oncology for developing novel biomarkers and therapeutic targets against refractory childhood cancers.
Dr. Mody’s primary research interest includes use of precision oncology approach for designing innovative clinical trials for refractory childhood cancers. Dr. Mody is leading a clinical trial investigating the role of next generation sequencing (NGS) in precision oncology for developing novel biomarkers and therapeutic targets against refractory childhood cancers.
Research Interests
Papers共 215 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Seema Chugh,Jean C. Tien,Jennifer Hon,Carson Kenum,Rahul Mannan,Yunhui Cheng, Chi Chiang Li, Zainab I. Taher,Andrew D. Delekta,Pushpinder Singh Bawa,Ingrid J. Apel, Stephanie J. Miner,
Neoplasiapp.100964, (2024)
CANCER MEDICINEno. 6 (2024)
Cancer medicineno. 6 (2024): e7106-e7106
CANCER MEDICINEno. 7 (2024): e6966-e6966
Translational pediatricsno. 2 (2024): 370-375
PEDIATRIC BLOOD & CANCERno. 3 (2024)
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Societypp.10935266241257547-10935266241257547, (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn